Skip to content

A single dose Levodopa study to balance goal-directed and habitual behavior in schizophrenia

A single dose Levodopa study to balance goal-directed and habitual behavior in schizophrenia - Single-dose levodopa in schizophrenia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON39093
Enrollment
30
Registered
2012-11-02
Start date
2013-04-01
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

psychotic disorders

Interventions

Admission of a single dose of Sinemet

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: All patients will be recruited from the Psychiatry ward of the Erasmus Medical Center, Rotterdam, and diagnosed according to DSM-IV criteria by a senior psychiatrist Patients will be included if they meet the criteria for schizophrenia. Further inclusion criteria inpatients aged 18-35 years with a diagnosis of schizophrenia, stable on antipsychotic, with illness duration < 5 years

Exclusion criteria

Exclusion criteria: pregnancy, use of psychotropic medication other than benzodiazepines, serious neurological disorders. Subjects will also be excluded when they cannot understand Dutch language sufficiently to understand the purposes and implications of the experiment.

Design outcomes

Primary

MeasureTime frame
cognitive functioning as assessed by a habit formation task and a n-back working memory task

Secondary

MeasureTime frame
clinical variables as measured by a panss interview and two questionnaires

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)